You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

New Guidance on Management of Acetaminophen Poisoning

  • Authors: Richard Dart, MD, PhD; Lee Cantrell, PharmD; Michael E. Mullins, MD; Kennon Heard, MD, PhD; Karen E. Simone, PharmD, DABAT, FAACT
  • CME / ABIM MOC / CE Released: 8/10/2023
  • Valid for credit through: 8/10/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.75 ABIM MOC points

    Nurses - 0.75 ANCC Contact Hour(s) (0.75 contact hours are in the area of pharmacology)

    Pharmacists - 0.75 Knowledge-based ACPE (0.075 CEUs)

    IPCE - 0.75 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for emergency medicine physicians, intensivists, intensive care unit specialists, pediatricians, hospitalists, primary care/internal medicine physicians, pain management specialists, anesthesiologists, neurologists, and other clinicians who are managing pain with over-the-counter options.

The goal of this activity is for learners to be better able to recognize and manage acetaminophen poisoning in line with new guidelines.

Upon completion of this activity, participants will:

  • Demonstrate improved performance associated with
    • Implementing new guidance for the management of acetaminophen poisoning
  • Demonstrate greater confidence in their ability to
    • Consistently manage patients with acetaminophen poisoning according to the latest guidelines


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Richard Dart, MD, PhD

    Professor, Emergency Medicine-Medical Toxicology and Pharmacology
    Department of Emergency Medicine
    University of Colorado School of Medicine
    Aurora, Colorado
    Director, Rocky Mountain Poison and Drug Safety
    Denver Health and Hospital Authority
    Denver, Colorado

    Disclosures

    Richard Dart, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Ophirex Pharma
    Research funding from: BTG International Ltd.; Collegium Pharmaceutical; Indivior PLC; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Ophirex Pharma; Purdue Pharma L.P.

  • Lee Cantrell, PharmD

    Clinical Professor
    UCSF School of Pharmacy
    San Francisco, California
    UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences
    Director, California Poison Control System, San Diego Division
    San Diego, California

    Disclosures

    Lee Cantrell, PharmD, has no relevant financial relationships.

  • Michael E. Mullins, MD

    Associate Professor
    Division of Medical Toxicology
    Department of Emergency Medicine
    Washington University School of Medicine
    St. Louis, Missouri

    Disclosures

    Michael E. Mullins, MD, has no relevant financial relationships.

  • Kennon Heard, MD, PhD

    Professor, Emergency Medicine-Medical Toxicology and Pharmacology
    Department of Emergency Medicine
    University of Colorado School of Medicine
    Aurora, Colorado
    Faculty, Rocky Mountain Poison and Drug Safety
    Denver, Colorado

    Disclosures

    Kennon Heard, MD, PhD, has no relevant financial relationships.

  • Karen E. Simone, PharmD, DABAT, FAACT

    Assistant Professor of Emergency Medicine
    Tufts University School of Medicine
    Director, Northern New England Poison Center
    MaineHealth/Maine Medical Center
    Portland, Maine

    Disclosures

    Karen E. Simone, PharmD, DABAT, FAACT, has no relevant financial relationships.

Editor

  • Kathy Merlo

    Medical Education Director, Medscape, LLC 

    Disclosures

    Kathy Merlo has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

    Contact This Provider

    For Nurses

  • Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.75 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) (Universal Activity Number: JA0007105-0000-23-292-H05-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit(s)™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

New Guidance on Management of Acetaminophen Poisoning

Authors: Richard Dart, MD, PhD; Lee Cantrell, PharmD; Michael E. Mullins, MD; Kennon Heard, MD, PhD; Karen E. Simone, PharmD, DABAT, FAACTFaculty and Disclosures

CME / ABIM MOC / CE Released: 8/10/2023

Valid for credit through: 8/10/2024, 11:59 PM EST

processing....

Contents of This CME Activity

To start this activity, please assess your clinical knowledge by completing the brief survey at the bottom. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

New Guidance on Management of Acetaminophen Poisoning

Dr Dart offers an overview of new consensus-based recommendations for the clinical management of acetaminophen poisoning.
Richard Dart, MD, PhD

Crucial Role of the History in Acetaminophen Poisoning

Drs Cantrell and Dart discuss the importance of a history in the management of acetaminophen poisoning.
Lee Cantrell, PharmD; Richard Dart, MD, PhD

Managing the Patient With an Acute Ingestion

Drs Mullins and Cantrell discuss patient scenarios in the management of acute acetaminophen ingestion.
Michael E. Mullins, MD; Lee Cantrell, PharmD

Management of Repeated Acetaminophen Ingestion

Drs Heard and Simone discuss the management of repeated supratherapeutic ingestions.
Kennon Heard, MD, PhD; Karen E. Simone, PharmD, DABAT, FAACT

The Use of Acetylcysteine in the Management of Acetaminophen Poisoning

Drs Dart and Heard discuss the starting and stopping criteria for acetylcysteine.
Richard Dart, MD, PhD; Kennon Heard, MD, PhD

Why and When to Contact Poison Center or Other Consultants

Drs Simone and Mullins discuss when to speak to a specialist in poison information or clinical toxicologist.
Karen E. Simone, PharmD, DABAT, FAACT; Michael E. Mullins, MD

New Guidance on Management of Acetaminophen Poisoning: Concluding Remarks

Dr Dart discusses important points in the management of acetaminophen poisoning.
Richard Dart, MD, PhD
 

Learning Feedback Questions

Please answer these questions to complement your learning experience.

  • Print